FDA Webview
X

Free FDA Notices

Public Meeting on IT Resources in Reviewing NDAs

09/21/2007

Federal Register Notice: FDA solicits comments on the information collection contained in regulations governing the use of radioactive drugs for basic informational research. No basic research study involving any administration of a radioactive drug to research subjects is permitted without the authorization of an FDA-approved radioactive drug research committee. The type of research that may be undertaken with a radiopharmaceutical drug must be intended to obtain basic information and not to carry out a clinical trial for safety or efficacy. Comments should be submitted by 11/20. To view this notice, click here.

LATEST NEWS